7148 DPHARMA
- 1.230
- +0.060+5.13%
DPHARMA News
DPHARMA: Quarterly rpt on consolidated results for the financial period ended 30/06/2024
DPHARMA: Quarterly rpt on consolidated results for the financial period ended 31/03/2024
DPHARMA: Quarterly rpt on consolidated results for the financial period ended 31/12/2023
DPHARMA: Quarterly rpt on consolidated results for the financial period ended 30/09/2023
DPHARMA: Quarterly rpt on consolidated results for the financial period ended 30/06/2023
Duopharma Biotech: Quarterly rpt on consolidated results for the financial period ended 31/03/2023
Duopharma Biotech: Quarterly rpt on consolidated results for the financial period ended 31/12/2022
Duopharma Biotech: Quarterly rpt on consolidated results for the financial period ended 30/09/2022
Duopharma Biotech: Quarterly rpt on consolidated results for the financial period ended 30/06/2022
Duopharma Biotech: Quarterly rpt on consolidated results for the financial period ended 31/03/2022
Duopharma Biotech: Quarterly rpt on consolidated results for the financial period ended 31/12/2021
Duopharma Biotech: Quarterly rpt on consolidated results for the financial period ended 30/09/2021
Duopharma Biotech: Quarterly rpt on consolidated results for the financial period ended 30/06/2021
Duopharma Biotech: Quarterly rpt on consolidated results for the financial period ended 31/03/2021
Duopharma Biotech: Quarterly rpt on consolidated results for the financial period ended 31/12/2020
Duopharma Biotech: Quarterly rpt on consolidated results for the financial period ended 30/09/2020
Duopharma Biotech: Quarterly rpt on consolidated results for the financial period ended 30/06/2020 (Amended Announcement)
Duopharma Biotech: Quarterly rpt on consolidated results for the financial period ended 30/06/2020
Duopharma Biotech: Quarterly rpt on consolidated results for the financial period ended 31/03/2020
Duopharma Biotech: Quarterly rpt on consolidated results for the financial period ended 31/12/2019
Analysis
Price Target
No Data
